Dialkyl bisphosphonate platinum(II) complex as a potential drug for metastatic bone tumor

Chemical and Pharmaceutical Bulletin

Volumn 59, Issue 6, 2011, Pages 710-713

  Nakatake, Hidetoshi ^a,b   Ekimoto, Hisao ^b   Aso, Mariko ^a   Ogawa, Atsushi ^a   Yamaguchi, Asami ^a   Suemune, Hiroshi ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b TMRC Co Ltd   (Japan)

Author keywords

Bisphosphonate; Hydroxyapatite affinity; Metastatic bone tumor; Platinum complex

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CARBOPLATIN; CISPLATIN; DIALKYL BISPHOSPHONATE PLATINUM COMPLEX; HYDROXYAPATITE; PLATINUM COMPLEX; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; AQUEOUS SOLUTION; ARTICLE; BONE TUMOR; CANCER GROWTH; CONTROLLED STUDY; DRUG ADSORPTION; DRUG INHIBITION; DRUG STABILITY; DRUG SYNTHESIS; HUMAN; HUMAN CELL; IN VITRO STUDY;

ADSORPTION; ANTINEOPLASTIC AGENTS; BONE NEOPLASMS; CARBOPLATIN; CELL LINE, TUMOR; CISPLATIN; COORDINATION COMPLEXES; DIPHOSPHONATES; DURAPATITE; HUMANS; NEOPLASM METASTASIS; OSTEOCLASTS; PLATINUM;

EID: 79957874301     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.59.710     Document Type: Article

References (20)

1. Gil L., Han Y., Opas E. E., Rodan G. A., Ruel R., Seedor J. G., Tyler P. C., Young R. N., Bioorg. Med. Chem., 7, 901-919 (1999).
2. Page P. C. B., Moore J. P. G., Mansfield I., McKenzie M. J., Bowlerb W. B., Gallagher J. A., Tetrahedron, 57, 1837-1847 (2001).
3. El-Mabhouh A. A., Angelov C. A., Cavell R., Mercer J. R., Nucl. Med. Biol., 33, 715-722 (2006).
4. Doschak M. R., Kucharski C. M., Wright J. E. I., Zernicke R. F., Uludag H., Mol. Pharm., 6, 634-640 (2009).
5. Hamilton C. R., Bliss J. M., Horwich A., Eur. J. Cancer Clin. Oncol., 25, 185-189 (1989).
6. Boulikas T., Vougiouka M., Oncol. Rep., 10, 1663-1682 (2003).
7. Ho Y. P., Au-Yeung S. C. F., To K. K. W., Med. Res. Rev., 23, 633-655 (2003).
8. Raymond E., Chaney S. G., Taamma A., Cvitkovic E., Ann. Oncol., 9, 1053-1071 (1998).
9. Speer R. J., Stewart D. P., U. S. Patent 4739087 (1988).
10. Odani A., U. S. Patent 7342122 (2008).
11. Ekimoto H., Int. Patent WO2009/008345 A1 (2009).
12. Reddy G. V., Jacobs H. K., Gopalan A. S., Barrans R. E. Jr., Dietz M. J., Stepinski D. C., Herlinger A. W., Synth. Commun., 34, 331-344 (2004).
13. Battle A. R., Platts J. A., Hambley T. W., Deacon G. B., J. Chem. Soc., Dalton Trans., 2002, 1898-1902 (2002).
14. Palazzo B., Iafisco M., Laforgia M., Margiotta N., Natile G., Bianchi C. L., Walsh D., Mann S., Roveri N., Adv. Funct. Mater., 17, 2180-2188 (2007).
15. Hengst V., Oussoren C., Kissel T., Storm G., Int. J. Pharm., 331, 224-227 (2007).
16. Ishiyama M., Tominaga H., Shiga M., Sasamoto K., Ohkura Y., Ueno K., Biol. Pharm. Bull., 19, 1518-1520 (1996).
17. Rixe O., Ortuzar W., Alvarez M., Parker R., Reed E., Paull K., Fojo T., Biochem. Pharmacol., 52, 1855-1865 (1996).
18. Takesita S., Kaji K., Kudo A., J. Bone Miner. Res., 8, 1477-1488 (2000).
19. Schnurr B., Gust R., Microchim. Acta, 140, 69-76 (2002).
20. Jerremalm E., Videhult P., Alvelius G., Griffiths W. J., Bergman T., Eksborg S., Ehrsson H., J. Pharm. Sci., 91, 2116-2121 (2002).